Neogenomics
Market cap
$2.135 B
$16.50 -3.79%
Close of 6 Nov 2026
As of 6 Nov 2026, Neogenomics (NEO) has a market capitalization of $2.13B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
—
Not reported
Earnings
-$108.0M
Loss-making
Shares outstanding
129,389,465
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Precision Instruments, ranked by market cap
All 3 →- #1UL SolutionsULS$15.5B
- #2NeogenomicsNEO$2.13B
- #320/20 BiolabsAIDX$2.47M
What if Neogenomics were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Neogenomics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.